Impact of Liver Metastasis on First-Line Immunotherapy in Stage IV Non-Small Cell Lung Cancer

BACKGROUND: Immunotherapy has become a key component of systemic therapy in stage IV non-small cell lung cancer (NSCLC). However, there have been conflicting reports of its efficacy in patients with liver metastasis (LM). METHODS: Using National Cancer Database (NCDB), patients who have been diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Komiya, Takefumi, Takamori, Shinkichi, Shimokawa, Mototsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409553/
https://www.ncbi.nlm.nih.gov/pubmed/37560341
http://dx.doi.org/10.14740/wjon1625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409553/
https://www.ncbi.nlm.nih.gov/pubmed/37560341
http://dx.doi.org/10.14740/wjon1625

Ejemplares similares